Violaxanthin
Violaxanthin is a diepoxy xanthophyll carotenoid found abundantly in green algae, spinach, and orange peel, where it functions as a light-harvesting and photoprotective pigment. Preliminary laboratory research suggests it may protect skin cells from UVB-induced oxidative damage and inhibit proliferation in certain cancer cell lines, though no human clinical trials have been conducted.
Origin & History
Violaxanthin is a xanthophyll carotenoid biosynthesized from zeaxanthin through the intermediate antheraxanthin, occurring exclusively in photosynthetic eukaryotes including plants, algae (particularly Nannochloropsis oceanica), and green thalli. It is extracted through cultivation optimization of microalgae, followed by chromatographic purification, or produced via engineered yeast (Saccharomyces cerevisiae) or bacterial systems.
Historical & Cultural Context
No evidence of historical or traditional medicinal use was identified in any cultural system. Violaxanthin's role has been primarily studied in the context of plant photoprotection rather than human health applications.
Health Benefits
• Photoprotective effects against UVB radiation damage in human skin cells (preliminary in vitro evidence only) • Anti-proliferative activity against human cancer cell lines (preliminary in vitro evidence only) • Anti-inflammatory properties in cancer cell models (preliminary in vitro evidence only) • Proapoptotic activity in cancer cells (preliminary in vitro evidence only) • Potential cellular protection through antioxidant mechanisms (theoretical based on carotenoid structure, no direct evidence)
How It Works
Violaxanthin exerts photoprotective effects partly by quenching reactive oxygen species (ROS) generated by UVB radiation, potentially reducing lipid peroxidation and DNA strand breaks in keratinocytes. Its anti-proliferative activity in cancer cell lines appears linked to modulation of apoptotic pathways, including caspase activation and downregulation of pro-survival signals such as Bcl-2, though the precise receptor targets remain uncharacterized. Anti-inflammatory effects observed in vitro are tentatively attributed to inhibition of pro-inflammatory cytokine expression, including reduced NF-κB pathway signaling in cancer cell models.
Scientific Research
No human clinical trials, randomized controlled trials, or meta-analyses have been conducted on violaxanthin supplementation. Current evidence is limited to in vitro studies showing photoprotective effects against UVB-irradiated human dermal fibroblasts and anti-cancer activity in human cell lines, with no PMIDs available in the provided research.
Clinical Summary
All available evidence for violaxanthin's health effects derives exclusively from in vitro cell-based studies; no human clinical trials, animal intervention studies, or epidemiological data have been published as of 2024. Photoprotective effects were demonstrated in human keratinocyte cell lines exposed to UVB radiation, showing reduced markers of oxidative stress, but sample sizes in cell studies are not directly comparable to human trial enrollment. Anti-proliferative effects have been observed against select human cancer cell lines, including certain breast and colon cancer models, with IC50 values reported in the low micromolar range, but these concentrations have not been validated as physiologically achievable in humans. The overall evidence base is considered very preliminary, and no efficacy conclusions can be drawn for human supplementation.
Nutritional Profile
Violaxanthin is a pure xanthophyll carotenoid compound (not a whole food ingredient), so it does not contain macronutrients, fiber, or protein in itself. Molecular formula: C40H56O4, molecular weight: 600.87 g/mol. It is a diepoxy carotenoid derived structurally from zeaxanthin through double epoxidation at the 5,6 and 5',6' positions. As a pure bioactive compound, its 'profile' is defined by its physicochemical and bioactive characteristics: it is a fat-soluble pigment belonging to the xanthophyll subclass of carotenoids, absorbing light maximally at approximately 440–470 nm (blue-green region). Natural sources include green leafy vegetables (spinach contains approximately 0.3–1.2 mg/100g fresh weight), microalgae such as Nannochloropsis and Dunaliella species (concentrations up to 5–10 mg/g dry weight in certain algae), marigold petals, and various fruits. Bioavailability is limited due to its high lipophilicity and epoxide groups, which may undergo acid-catalyzed transformation to auroxanthin in the gastrointestinal tract; co-consumption with dietary fat is required for micellarization and absorption. No established dietary reference intake exists. It participates in the xanthophyll cycle in plants, converting to antheraxanthin and zeaxanthin under high-light conditions. Antioxidant capacity is measurable via ORAC and DPPH assays but is generally lower than zeaxanthin or astaxanthin due to the epoxide modifications reducing conjugated double bond length.
Preparation & Dosage
No clinically studied dosage ranges are available as human trials have not been conducted. No standardized forms (extract, powder) or dosing protocols exist. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
zeaxanthin, lutein, antheraxanthin, neoxanthin, other carotenoids
Safety & Interactions
No human safety data, toxicology studies, or established tolerable upper intake levels exist specifically for violaxanthin supplementation, making formal risk assessment impossible at this time. Because violaxanthin is a fat-soluble carotenoid, theoretical concerns include potential accumulation in adipose tissue with prolonged high-dose intake, though no adverse effects have been documented even in cell or animal models. No known drug interactions have been identified, but caution is warranted alongside medications metabolized via carotenoid-sensitive pathways or in individuals taking high-dose mixed carotenoid supplements. Pregnant and breastfeeding individuals should avoid supplemental violaxanthin due to a complete absence of safety data in these populations.